It’s only fair to share… Omidenepag isopropyl DE-117 Glycine, N-(6-((((4-(1H-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)-2-pyridinyl)-, 1-methylethyl ester [[6-[[[4-(Pyrazol-1-yl)benzyl](pyridin-3-ylsulfonyl)amino]methyl]pyridin-2-yl]amino]acetic acid isopropyl ester C26H28N6O4S, 520.6033, CAS: 1187451-19-9 APPROVED 2018/9/21 PMDA, JAPAN 2018, Eybelis Antiglaucoma, Prostaglandin E2 receptor agonist, Treatment of Open-Angle Glaucoma and Ocular Hypertension Originator Ube Industries Developer Santen Pharmaceutical Class Eye disorder therapies; Pyrazoles; Pyridines; Small molecules; Sulfonamides Mechanism of Action Prostaglandin E EP2 receptor agonists Registered Glaucoma; Ocular hypertension …